Mayo Clinic Phenomix, Mayo Clinic Ink Licensing Deal for Obesity Phenotype Blood Test Phenomix said its MyPhenome test uses a multiomics and artificial intelligence platform to predict patients' obesity phenotypes. WuXi Diagnostics Closes $150M Series B Financing Round The Chinese company said it would use some of the funding to advance its integrated diagnostics research and development pipeline. BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions Researchers reclassified 86 percent of variants initially determined to be VUS, potentially changing surveillance or treatment approaches for patients. Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers The partners will use mass spec to look at markers in Barrett's patients who either progressed to more severe disease states or remained stable over a 10-year period. Cue Health Ramping Up COVID-19 Test Production Following Positive Mayo Clinic Study, DoD Funding Premium The test uses isothermal nucleic acid amplification to return results in 20 minutes at the point of care, and demonstrated 98 percent agreement with PCR testing. Jan 21, 2021 Breast Cancer Risk Gene Associations Refined in Large-Scale Studies Dec 15, 2020 Life Sciences Software Company Nference Completes $60M Series C Funding Round Nov 19, 2020 Putting Expanded Carrier Screening Into Practice Requires Considerations to Avoid Pitfalls Premium Oct 30, 2020 Broad Genetic Testing Uncovers Additional Risk Variants in Cancer Patients, Study Finds Sep 15, 2020 Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles Sep 10, 2020 Longitudinal Irritable Bowel Syndrome Omics Study Points to Possible Treatment Target Aug 25, 2020 Trial Shows Some Benefit of Genetically Guided Antiplatelet Therapy After Balloon Angioplasty May 7, 2020 Coronary Heart Disease Polygenic Risk Scores Differ in Utility Between Ethnic Groups Apr 22, 2020 Mayo Clinic Coronavirus Assay Gets Emergency Use Authorization Apr 10, 2020 Free Bioinformatics Tool From Nference, Janssen Uncovers New COVID-19 Insights Mar 6, 2020 As Consumer Genomics Market Cools, Providers Ponder Better Ways to Reach Customers Premium Feb 26, 2020 Congressional Caucus Working to Raise Personalized Medicine Awareness Among Legislators Premium Feb 12, 2020 Exact Sciences Boosting Position in Cancer Dx Market Through M&A Premium Feb 10, 2020 Through Mayo Clinic Pact, PGDx Hopes to Show Clinical Utility for NGS Tissue, Liquid Biopsy Assays Premium Jan 29, 2020 Nference Poised for Growth Following Mayo Clinic Investment, Partnership Premium Jan 14, 2020 Nference Named First Partner for New Mayo Clinical Analytics Platform Jan 9, 2020 Mayo Clinic, Helix Partner for 100K-Patient Clinical Genomics Study Premium Jan 8, 2020 Novel Duplication Uncovered in Amish Individuals Explains Exercise-Associated Sudden Death Jan 8, 2020 Personal Genome Diagnostics, Mayo Clinic to Collaborate on Cancer Genomic Tests Jan 8, 2020 Nference Raises $60M in Series B Investment Round Load More Breaking News IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio' Polynesian Island Population History Revealed From Present-Day Human Genomes Aviv Scientific Closes $40M Series B Financing Round Roche Nabs CE Mark for Three Cobas Respiratory Test Panels Hexagon Bio Raises $61M in Private Financing Round GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing The Scan Not Yet a Permanent One NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials. Unfair Targeting Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases. Limited Rapid Testing The New York Times wonders why rapid tests for COVID-19 are not widely available in the US. Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.